Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2024 03:00 ET | Source: FUJIFILM Europe GmbH

FUJIFILM Healthcare Europe announces ARIETTA 750 FF ENDO compatibility with FUJIFILM ultrasound endoscopes and endobronchial ultrasound scope

RATINGEN, Germany, Sept. 06, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is excited to announce the compatibility between the high-end Ultrasound system ARIETTA 750 FF ENDO and the...
July 16, 2024 03:00 ET | Source: FUJIFILM Europe GmbH

FUJIFILM Healthcare Europe announces revolutionary Detective Flow Imaging (DFI) technology compatibility with mainstream EG-580UT endoscope

RATINGEN, Germany, July 16, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce that the Detective Flow Imaging feature (DFI) of the premium ARIETTA 850 FF Endo...
April 19, 2024 03:00 ET | Source: FUJIFILM Europe GmbH

Fujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel

RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal...
July 03, 2023 03:00 ET | Source: FUJIFILM Sonosite, Inc.

FUJIFILM Sonosite Introduces the All-Touchscreen Sonosite ST POCUS System, Designed and Engineered to Support Procedural Workflows

BOTHELL, Wash., July 03, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the...
February 02, 2023 13:57 ET | Source: Kymanox Corporation

Kymanox Acquires EU based Anteris Medical and Anteris Helvetia

MORRISVILLE, N.C. and HOLZKIRCHEN, Germany and KÜSSNACHT A.R., Switzerland, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively...
May 26, 2021 11:00 ET | Source: Juvenile Diabetes Research Foundation

L'engagement de financement contribue à supprimer les obstacles qui empêchent les Canadiens atteints de diabète de type 1 d'accéder à des technologies conçues pour leur survie.

TORONTO, 26 mai 2021 (GLOBE NEWSWIRE) -- Chaque jour, pas moins de 300 000 Canadiens atteints de diabète de type 1 (DT1) devront prendre jusqu'à 300 décisions sur leurs soins. Une mauvaise décision...
May 26, 2021 11:00 ET | Source: Juvenile Diabetes Research Foundation

Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetes

TORONTO, May 26, 2021 (GLOBE NEWSWIRE) -- Each day, as many as 300,000 Canadians living with type 1 diabetes (T1D) will make up to 300 decisions about their care. A wrong decision could mean life or...